Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic.
Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic.
复制标题
DOI：
10.1016/j.jsat.2020.108161
复制
发表时间：
2021-03
影响因子：
3.9
通讯作者：
Winkelman TNA
中科院分区：
文献类型：
--
作者：
Duncan A;Sanders N;Schiff M;Winkelman TNA
惩教设施是COVID-19传播的最高风险环境之一。在COVID-19大流行之前，明尼苏达州明尼阿波利斯市的Hennepin县监狱为所有患有中度至重度阿片类药物使用障碍（OUD）的监狱居民提供短期美沙酮维持治疗、丁丙诺啡启动和维持治疗以及纳洛酮启动和维持治疗。为了应对疫情，监狱减少了43%的人口。针对COVID-19公共卫生紧急状态声明，监狱人口普查减少，联邦远程医疗法规放宽，允许监狱进行修改，允许个人在没有与临床医生进行首次面对面访问的情况下开始丁丙诺啡。监狱还制定了丁丙诺啡锥度桥梁个人维护或提供戒断管理，这取决于病人的喜好。随着监狱人口普查的减少，远程访问的使用以及丁丙诺啡治疗计划的修改，临床医生能够满足OUD的治疗需求。一些监狱可能需要额外的资金流来抵消与流行病有关的医疗费用。
Correctional facilities are among the highest-risk settings for the spread of COVID-19. Prior to the COVID-19 pandemic, the Hennepin County Jail in Minneapolis, Minnesota, offered short-term methadone maintenance, buprenorphine initiation and maintenance, and naltrexone initiation and maintenance to all jail residents with moderate to severe opioid use disorder (OUD). In response to the pandemic, the jail reduced its population by 43%. The reduced jail census and relaxed federal telemedicine regulations in response to the COVID-19 public health emergency declaration allowed the jail to institute modifications that permitted individuals to start buprenorphine without an initial in-person visit with a clinician. The jail also instituted a buprenorphine taper to bridge individuals to maintenance or provide withdrawal management, depending on patient preference. With a decreased jail census, the use of remote visits, and modifications to the buprenorphine treatment program, clinicians are able to meet the OUD treatment demand. Some jails may need additional funding streams to offset pandemic-related health treatment costs.
影响因子：
9.7
作者：
Reinhart, Eric;Chen, Daniel L.
通讯作者：
Chen, Daniel L.
影响因子：
2.3
作者：
Wakeman, Sarah E.;Rich, Josiah D.
通讯作者：
Rich, Josiah D.
影响因子：
12.7
作者：
Ranapurwala, Shabbar I.;Shanahan, Meghan E.;Marshall, Stephen W.
通讯作者：
Marshall, Stephen W.